Chemoembolizaton/Drug-Eluting Embolics

(1) Chemoembolization for Renal Cell Carcinoma: Revisiting an Underexplored Locoregional Therapy

(3) Bridging and Downstaging in HCC: Role of TACE vs TARE in Transplant Eligibility

(18) Emerging Role of Transarterial Chemoembolization in Lung Cancer: Feasibility, Integration, and Future Directions

(24) Refining the Role of TACE in HCC: Patient Populations That May Benefit Beyond BCLC B

(25) Optimizing Patient Selection for Locoregional Therapies in HCC: A Comparative Overview of TACE and TARE

(41) Transarterial Chemoembolization Alone and with Immunotherapy for Treating Hepatocellular Carcinoma: Current Evidence

(42) Targeting Breast Cancer in the Liver: Comparative Insights on Transarterial Chemoembolization and Radioembolization

(43) Locoregional Therapy in Ovarian Cancer Metastasis: An Area Necessitating Further Investigation

(51) Comparing Embolic Materials in TACE and TARE: Morphology, Vascular Distribution, and Clinical Outcomes

(52) Comparison of Doxorubicin and Alternative Chemotherapeutics in DEB-TACE

(73) Transarterial Therapy in Non-Hepatocellular Carcinoma Liver Tumors: Expanding Indications and Evidence Base

(75) Locoregional and Immunotherapy Integration for Hepatocellular Carcinoma: Mechanistic Rationale and Trial Landscape

(89) Transarterial Therapy in Bone Metastases: Evidence for Pain Palliation, Local Control, and Perioperative Outcomes

(90) Therapeutic Potential of Transarterial Chemoembolization in Osteosarcoma: A New Path Forward